Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What CAGR And Valuation Are Anticipated For The Precision Medicine Market?
The market size for precision medicine has seen robust growth in recent years, expanding from $80.15 billion in 2024 to an expected $87.91 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this significant growth during the historic period include the rising incidence of cancer, an upswing in mental health disorders, a surge in respiratory diseases, increased funding, a growing elderly population, higher spending in pharmaceutical R&D, and augmented healthcare expenditure.
The market for precision medicine is anticipated to witness robust expansion in the coming years, with predictions of a rise to $126.14 billion in 2029, reflecting a compound annual growth rate (CAGR) of 9.4%. This growth expectation in the prognosis period is due to factors like the rising elderly population, increased occurrence of cancer, promising potential of developing economies, the appearance of new pathogenic infections, escalation in research and development investment, and increased healthcare spending. Key trends expected in the prognosis period features the adoption of artificial intelligence capabilities to enhance competitiveness, delivering diagnoses and customized treatments for immune-related diseases, investing in heightened research and development efforts, and initiating alliances and partnerships with tech and healthcare organizations to bolster their product offerings.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5301&type=smp
What Are The Primary Factors Supporting The Precision Medicine Market Expansion?
The escalating incidence rate of cancer is expected to boost the expansion of the precision medicine market. Cancer, a leading global cause of death, affects one in every five individuals during their lifetime. The use of precision medicine in treating cancer involves examining tumor DNA to identify mutations or other genetic irregularities contributing to cancer. As a result, doctors can select a treatment that is most effective for a particular cancer patient, targeting the specific changes in tumor DNA. For example, the World Health Organization, a Switzerland-based entity focused on international public health, reported in February 2024 that by 2050, there will be over 35 million new cases of cancer, signifying a 77% increase from the projected 20 million cases in 2022. Consequently, the escalating incidence of cancer stimulates the expansion of the precision medicine market.
What Is The Segment Breakdown Of The Precision Medicine Market?
The precision medicine market covered in this report is segmented –
1) By Technology: Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, Other Technology
2) By Application: Oncology, Respiratory Diseases, Central Nervous System Disorders, Immunology, Genetic Diseases, Other Applications.
3) By End-Use: Pharmaceutical Companies, Diagnostic Companies, Healthcare And IT Firms, Others
Subsegments:
1) By Big Data Analytics: Predictive Analytics, Prescriptive Analytics, Data Mining
2) By Bioinformatics: Genomic Data Analysis, Proteomics Data Analysis, Metabolomics Data Analysis
3) By Gene Sequencing: Next-Generation Sequencing (NGS), Sanger Sequencing, Whole Genome Sequencing
4) By Drug Discovery: Target Identification And Validation, Lead Compound Discovery, Preclinical And Clinical Trials
5) By Companion Diagnostics: Biomarker Testing, Genomic Profiling, Companion Diagnostic Tests
6) By Other Technology: Personalized Treatment Plans, Telemedicine And Digital Health Solutions, Wearable Health Technology
How Are Global Trends Impacting The Development Of The Precision Medicine Market?
The increase in collaborations and acquisitions among firms within the precision medicine industry is facilitating their expansion into both cancer-related and non-oncology areas. Precision medicine continues to evolve through constant research and development in new sectors. Collaborations and partnerships aid these companies in amplifying their abilities and methods. An example of this occurred in September 2022 when GSK plc, a pharmaceutical firm based in the UK, broadened their collaboration with Tempus, a precision medicine company located in the US. The goal of this three-year partnership is to bolster clinical trial design, expedite patient enrollment, and pinpoint drug targets through the application of Tempus’ AI-enabled platform and vast de-identified patient data. Building upon their previous endeavors, this collaboration is anticipated to augment GSK’s research and development capabilities, specifically in the field of oncology.
Who Are The Major Stakeholders Operating In The Precision Medicine Market?
Major companies operating in the precision medicine market include Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report
Which Region Is Likely To Register The Fastest Growth In The Precision Medicine Market?
North America was the largest region in the precision medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=5301&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
